Scientifically, PT-141 is a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (-MSH), specifically targeting the melanocortin-4 receptor (MC4R) to enhance sexual signaling without affecting blood pressure or heart rate like some other treatments.[4] At the most basic level, PT-141 activates brain centers that control sexual desire, increasing blood flow to genital tissues, improving sensitivity, and promoting natural lubricationall without relying on hormonal changes, making it suitable for women who can't or prefer not to use estrogen-based therapies.[4] Its role goes far beyond just sparking interest
16 Similarly, calcitonin, a peptide hormone used in osteoporosis treatment, has been successfully delivered intranasally, offering a precedent for GLP-1 analogs
LD hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis
(NewsNation) A new experimental weight loss drug that targets three hormones simultaneously may outperform Ozempic and Mounjaro, but patients need close medical supervision to use it safely, a regenerative medicine physician said
Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis
Sairam K, Priyambada S, Aryya NC, Goel RK